Zoekresultaten - 1 result

Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.

for most vaccines not performed. At the Belgian Scientific institute of public health, MPL content is determined for batch release of a human papilloma virus vaccine and a hepatitis B vaccine. Testing ...

QR code

QR code for this page URL